A few months ago we reported on a drug company called ZMapp that was testing, and having some luck, treating Ebola patients with a drug sourced from a tobacco plant. Now ZMapp, working alongside Vanderbilt University, have received a donation of blood from an Ebola survivor, hoping to extract and map Ebola survivor’s proteins leading eventually to a cure.
Cure for Ebola could lie in survivor’s blood
More of Today's Solutions
Why the poo taboo has held back a killer disease, and what’s changing
BY THE OPTIMIST DAILY EDITORIAL TEAM There is a disease that kills more than one million people a year, nearly half of them children ...
Read MoreRage workouts don’t calm you down, research finds. Here’s what does.
BY THE OPTIMIST DAILY EDITORIAL TEAM Slamming tires with a sledgehammer, pummeling a punching bag, running yourself into the ground when you're furious: the ...
Read MoreEating these 5 “sirtfoods” can support healthy aging
We recently published a story about how eating bitter melon can improve longevity. Remaining within the topic of healthy aging, today we bring you ...
Read More4 things that keep Canadian traffic fatalities lower than the US
While traffic-related fatalities increased in the United States by 19 percent between 2010 and 2020, Canadian rates declined by about the same amount in ...
Read More
